NIH Children’s Inn
Executive SummaryOpening ceremony for the new $5 mil. guest residence for National Institutes of Health pediatric patients and their families were held June 21. President Bush, HHS Secretary Sullivan, NCI Chief of Pediatrics Phillip Pizzo, MD, and Merck Chairman Roy Vagelos were among the speakers at the ceremony. Merck has donated $3.7 mil. for the construction of the inn. Other healthcare companies that have contributed to the project are Lederle, Warner-Lambert, J&J, SmithKline Beecham, Abbott, Baxter Labs, Bristol-Myers Squibb, DuPont, Pfizer, Schering-Plough, Searle, Upjohn, Sterling, Boehringer Ingelheim, Marion Merrell Dow and Sandoz.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.